Ardent Health Partners, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Dave Caspers, CEO and President of Ardent Health, Inc., reported the acquisition of 103,653 shares of common stock on July 1, 2026.
NYSE
Director Robert DeMichiei acquired 11,260 shares of Ardent Health, Inc. common stock for an average price of $8.73 per share.
NYSE
Ardent Health, Inc. Chief Financial Officer Alfred Lumsdaine acquired 10,000 shares of common stock on June 5, 2026.
NYSE
Peter J. Bulgarelli, a Director at Ardent Health, Inc., acquired 14,231 restricted stock units on April 1, 2026, as part of a compensation plan.
NYSE
Director Ellen Havdala acquired 14,231 shares of Ardent Health, Inc. common stock on April 1, 2026, as part of a restricted stock unit grant.
NYSE
R. Sotir Mark, Director and Chair of the Board at Ardent Health, Inc., acquired 14,231 shares of common stock on April 1, 2026.
NYSE
Director Rahul Sen reported the acquisition of 14,231 shares of Ardent Health, Inc. common stock on April 1, 2026.
NYSE
Ardent Health Director Robert Thomas Webb acquired 14,231 restricted stock units on April 1, 2026, vesting in full on the first anniversary.
NYSE
Director Edmondo Robinson acquired 14,231 shares of Ardent Health, Inc. common stock on April 1, 2026, as reported in a Form 4 filing.
NYSE
Director Robert DeMichiei reported the acquisition of 14,231 shares of Ardent Health, Inc. common stock on April 1, 2026.
NYSE
William M. Goodyear, a Director at Ardent Health, Inc., acquired 14,231 shares of common stock on April 1, 2026, as part of a restricted stock unit grant.
NYSE
Ardent Health Director Suzanne Campion acquired 14,231 shares of common stock on April 1, 2026, as part of a restricted stock unit grant.
NYSE
Ardent Health Director Peter C. Bynoe acquired 14,231 restricted stock units on April 1, 2026, as disclosed in a Form 4 filing.
NYSE
Ardent Health COO Dave Caspers reported the vesting of restricted stock units and a related tax withholding transaction.
NYSE
EVP, GC and Secretary Stephen C. Petrovich reported the vesting of restricted stock units and associated tax withholdings.
NYSE
SVP and Chief Accounting Officer David Raynor Byers reported the withholding of shares for tax obligations and the receipt of new restricted stock units.
NYSE
Ardent Health CFO Alfred Lumsdaine reported the vesting of restricted stock units and associated tax withholding transactions.
NYSE
Ardent Health CEO Martin Bonick disclosed the withholding of shares for tax obligations and the receipt of new restricted stock units.
NYSE
Ardent Health's EVP, GC, and Secretary, Stephen C. Petrovich, was awarded 34,733 shares of common stock based on 2024 and 2025 performance.
NYSE
Ardent Health's Chief Financial Officer, Alfred Lumsdaine, acquired 61,081 shares of common stock through the vesting of performance-based restricted stock units.
NYSE
Ardent Health's President of Health Services, Ethan Chernin, acquired 32,408 shares of common stock through a performance-based RSU award.
NYSE
Ardent Health's President and CEO, Martin Bonick, acquired 195,316 shares of common stock through the vesting of performance-based restricted stock units.
NYSE
Ardent Health's SVP & Chief Accounting Officer, David Raynor Byers, earned 8,859 shares of common stock based on performance vesting restricted stock units.
NYSE
Ardent Health, Inc.'s Chief Financial Officer, Alfred Lumsdaine, reported the withholding of 3,389 common shares for tax obligations following the vesting of restricted stock units.
NYSE
Ardent Health's EVP, GC, and Asst. Secretary, Stephen C. Petrovich, reported a disposition of 788 common shares for tax withholding purposes at $13.19 per share.
NYSE
Ardent Health's SVP & Chief Accounting Officer, David Raynor Byers, disposed of 524 shares of common stock to cover tax liabilities from restricted stock unit vesting.
NYSE
Robert DeMichiei, a director of Ardent Health Partners, acquired 10,073 shares of common stock on April 2, 2025.
NYSE
Dave Caspers, Chief Operating Officer of Ardent Health Partners, reports acquiring and disposing of common stock and restricted stock units on April 1, 2025.
NYSE
David Raynor Byers, SVP & Chief Accounting Officer of Ardent Health Partners, reports the acquisition and disposal of company stock.
NYSE
Ethan Chernin, President of Health Services at Ardent Health Partners, reports acquisition and disposal of company stock related to vesting of restricted stock units.